Get started
Author

Micol Maria Rigoni

Observed names: M Rigoni, M. Rigoni, Micol Rigoni, RIGONI, MICOL MARIA
Institution: University of Turin
OpenAlex ID: A5010750357
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
2015 · Barbara Castella, Myriam Foglietta, et al. · OncoImmunology · 69
PDF
Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study
2017 · Ilaria Buondonno, Guido Rovera, et al. · PLoS ONE · 65
PDF
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells
2011 · M Coscia, F Pantaleoni, et al. · Leukemia · 61
PDF
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
2012 · Marta Coscia, Candida Vitale, et al. · Blood · 60
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
2015 · Micol Rigoni, Chiara Riganti, et al. · Oncotarget · 38
PDF
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals
2010 · Marta Coscia, Francesca Pantaleoni, et al. · Blood · 2
Targeting Hif-1a and Its Regulatory Pathways as a Strategy to Hamper Leukemia-microenvironment Interactions in Chronic Lymphocytic Leukemia
2017 · Candida Vitale, Griggio, et al. · IrInSubria (University of Insubria)
The CXCR4 Downstream Signaling Pathways in Chronic Lymphocytic Leukemia: a Target to Reverse Microenvironment Protection
2016 · Candida Vitale, Valentina Griggio, et al. · Clinical Lymphoma Myeloma & Leukemia
Immune system and bone cells in early rheumatoid arthritis
2016 · Ilaria Buondonno, Francesca Sassi, et al. · Bone Abstracts
Targeting the Cxcr4 Downstream Signalling Pathways to Reverse Microenvironment Protection in Chronic Lymphocytic Leukemia Cells
2016 · Candida Vitale, Griggio, et al. · IrInSubria (University of Insubria)
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells
2014 · Candida Vitale, Valentina Griggio, et al. · Blood
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia
2014 · Valentina Griggio, Giorgia Mandili, et al. · IrInSubria (University of Insubria)
Identification and Functional Characterization of Antibody Immune Responses Elicited by Self Antigens in Chronic Lymphocytic Leukemia
2014 · Valentina Griggio, Giorgia Mandili, et al. · IrInSubria (University of Insubria)
Role of PD-1/PD-L1 axis in the immune paresis of bone marrow Vγ9Vδ2 T cells in multiple myeloma
2014 · Barbara Castella, Myriam Foglietta, et al. · IrInSubria (University of Insubria)
The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells
2014 · Micol Maria Rigoni, Chiara Riganti, et al. · IrInSubria (University of Insubria)
The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL)
2012 · Marta Coscia, Micol Rigoni, et al. · Blood
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)
2012 · Marta Coscia, Valentina Griggio, et al. · Blood
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells
2012 · Ivana Campia, Joanna Kopecka, et al. · IrInSubria (University of Insubria)
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL)
2012 · Valentina Griggio, Michela Capello, et al. · IrInSubria (University of Insubria)
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)
2012 · RIGONI, MICOL MARIA, COSCIA, Marta, et al. · Institutional Research Information System University of Turin (University of Turin)
The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells
2011 · Marta Coscia, Micol Rigoni, et al. · Blood
2.37 Accelerated Activity of the Mevalonate Pathway Supports the Immune Escape and Multidrug- Resistance Phenotype of IGHV Unmutated Chronic Lymphocytic Leukemia Cells
2011 · M. Coscia, M. Rigoni, et al. · Clinical Lymphoma Myeloma & Leukemia
2.28 Identification by Serological Proteome Analysis (SERPA) of Novel Tumor Associated Antigens in Chronic Lymphocytic Leukemia (CLL)
2011 · M. Coscia, V. Griggio, et al. · Clinical Lymphoma Myeloma & Leukemia
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells
2011 · Micol Maria Rigoni, Marta Coscia, et al. · IrInSubria (University of Insubria)
Serological Proteome Analysis (serpa) for the Identification of Tumor-associated Antigens Eliciting Antibody-responses in Chronic Lymphocytic Leukemia
2011 · Marta Coscia, Valentina Griggio, et al. · IrInSubria (University of Insubria)
Works count: 35
Citation count: 295
H-index: 5
I10-index: 5
Year
Topic
Type